Enanta Pharmaceuticals Inc. Revenue 2020–2025
Enanta Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Enanta Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 17.2 M.
- Enanta Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 69.2 M.
- Enanta Pharmaceuticals Inc. annual revenue for 2025 was 65.3 M, a 3.42% decrease from 2024.
- Enanta Pharmaceuticals Inc. annual revenue for 2024 was 67.6 M, a 14.61% decrease from 2023.
- Enanta Pharmaceuticals Inc. annual revenue for 2023 was 79.2 M, a 8.07% decrease from 2022.
- Enanta Pharmaceuticals Inc. annual revenue for 2022 was 86.2 M.
Enanta Pharmaceuticals Inc. (ENTA) — Frequently Asked Questions
Enanta Pharmaceuticals Inc. (ENTA) is a publicly traded US company. It has a market capitalization of $248M. In fiscal 2025 it reported revenue of $65M and net income of -$82M. Explore ENTA's stock price, financial statements, earnings history, margins and key ratios below.
What is Enanta Pharmaceuticals Inc.'s market cap?
Enanta Pharmaceuticals Inc. (ENTA) has a market capitalization of $248M.
What is the ENTA stock price?
ENTA trades at $11.63 (-0.56% on the day).
How much revenue does Enanta Pharmaceuticals Inc. make?
Enanta Pharmaceuticals Inc. reported revenue of $65M in fiscal 2025.
Is ENTA profitable?
In fiscal 2025, Enanta Pharmaceuticals Inc. reported net income of -$82M.